MP-2018

N/A

Report date: 2025/01/26 17:18:37
NME

Base Information

Drug NameMP-2018
Drug Alias NameRAL GTPase inhibitor (Machavert Pharmaceuticals)MP-2018
ClassificationSmall molecules > Lipid
Mechanisms of ActionGTPase inhibitors
TargetsGTPase
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMachavert Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesMachavert Pharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A